BARD PHARMACEUTICALS LIMITED
Get an alert when BARD PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2k
+100% vs 2024
Net assets
£70m
+4.3% vs 2024
Employees
353
0% vs 2024
Profit before tax
£7.4m
+1.5% vs 2024
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £93,184,000 | £104,099,000 | +11.7% | |
| Operating profit | £7,282,000 | £7,392,000 | +1.5% | |
| Profit before tax | £7,285,000 | £7,392,000 | +1.5% | |
| Net profit | £5,525,000 | £2,573,000 | -53.4% | |
| Cash | £1,000 | £2,000 | +100% | |
| Total assets less current liabilities | £74,424,000 | £82,102,000 | +10.3% | |
| Net assets | £66,962,000 | £69,828,000 | +4.3% | |
| Equity | £66,962,000 | £69,828,000 | +4.3% | |
| Average employees | 353 | 353 | 0% | |
| Wages | £19,468,000 | £20,087,000 | +3.2% | |
| Directors' remuneration | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating margin | 7.8% | 7.1% | |
| Net margin | 5.9% | 2.5% | |
| Return on capital employed | 9.8% | 9.0% | |
| Gearing (liabilities / total assets) | 47.4% | 46.6% | |
| Current ratio | 1.59x | 1.58x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company is a member of the Napp Pharmaceutical Holdings Limited group and is subject to the overall financing arrangements of the group. As such the Company has received a formal letter of support from the Company's ultimate parent company, Napp Pharmaceutical Holdings Limited, confirming continued financial support to enable the Company to meet its liabilities to creditors as they fall due through to 30 June 2027. ... Based on this assessment the directors continue to adopt the going concern basis in preparing the annual report and accounts.”
Significant events
- “On 21 January 2026, the trustees of the Napp Pharmaceutical Group Pension Scheme entered into a pension insurance buy-in contract with Rothesay Life plc for £182,300,000. As a result of this transaction the Scheme will receive regular payments from Rothesay Life to fund the majority of future benefit payments. By purchasing the insurance policy, the investment risk and longevity risk to which the Company was previously exposed have been substantially removed.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JAMIESON, Stephen Johan | Director | 2019-02-22 | Sep 1957 | British |
| LEA, Bryan George | Director | 2020-01-01 | Jun 1961 | British |
| VARSHNEY, Ajay | Director | 2024-06-14 | May 1974 | Indian |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORNHILL SERVICES LIMITED | Corporate Secretary | 2008-03-25 | 2009-02-26 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | 2009-02-26 | 2018-06-11 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | — | 2008-03-25 |
| BAKER, Stuart David | Director | 2017-08-08 | 2019-12-31 |
| BRADLEY, Dominic Michael, Dr | Director | 2023-02-03 | 2024-12-13 |
| BROGDEN, John Robert | Director | — | 2005-03-30 |
| CHAPLIN, John Richard | Director | — | 1999-09-09 |
| CLARKE, Robert Alan | Director | 2012-11-07 | 2015-12-31 |
| GOFF, Valerie May | Director | 1999-01-31 | 2015-12-31 |
| LESLIE, Stewart T | Director | — | 1997-12-31 |
| MANNERS, Paul | Director | — | 2001-12-31 |
| MATTESSICH, Antony Charles | Director | 2005-04-01 | 2017-07-31 |
| MITCHELL, Christopher Benbow | Director | — | 2018-04-12 |
| MOODY, Colm Joseph | Director | 2015-04-01 | 2022-06-30 |
| NICOL, Eric Gordan | Director | — | 1999-12-31 |
| WIKSTROM, Ake Gunnar | Director | 2018-04-12 | 2019-02-22 |
| WIKSTROM, Ake Gunnar | Director | 2001-09-05 | 2011-05-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Napp Pharmaceutical Group Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 170 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-21 | AA | accounts | Accounts with accounts type full | |
| 2026-06-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-17 | CH01 | officers | Change person director company with change date | |
| 2025-09-09 | AA | accounts | Accounts with accounts type full | |
| 2025-05-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-06 | AD02 | address | Change sail address company with old address new address | |
| 2024-12-13 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-12-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-12-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-08-27 | AA | accounts | Accounts with accounts type full | |
| 2024-06-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-14 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-04 | CH01 | officers | Change person director company with change date | |
| 2023-10-12 | AA | accounts | Accounts with accounts type full | |
| 2023-06-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-13 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-14 | AA | accounts | Accounts with accounts type full | |
| 2022-07-26 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-07-04 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.